It is a chemicals private limited company based in Agra, Uttar Pradesh, India, established in 2020.
2020 | Agra, Uttar Pradesh, India | ActiveStyron Pharmaceuticals Private Limited, a active private limited company, was established on 18 August 2020 in Agra, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24231UP2020PTC132850. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Rishabh Sharma (Director), Anshul Singh (Director). Past directors included Shivji Rawat. Its latest AGM occurred on 20 September 2025, with the balance sheet filed on 31 March 2025. It is based at House No.21 Sushil Nagar Naraich, Agra, Uttar Pradesh, 282001.
U24231UP2020PTC132850
132850
18 August 2020
₹0.10 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Styron Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rishabh Sharma | Director | 18 Aug 2020 | Current |
| Anshul Singh | Director | 18 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Styron Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 212.65% increase. The company also saw a substantial fall in profitability, with a 67.09% decrease in profit. The company's net worth moved up by a moderate rise of 0.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Styron Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Styron Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Styron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styron Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Styron Pharmaceuticals Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records. was documented.
Progress on Styron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.
Progress on Rishabh Sharma was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
Progress on Anshul Singh was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
Progress on Styron Pharmaceuticals Private Limited was registered on 18 Aug 2020 with Roc Kanpur & aged 5 years 4 months as per MCA records. was documented.
The CIN of Styron Pharmaceuticals Private Limited is U24231UP2020PTC132850.
Styron Pharmaceuticals Private Limited is headquartered at House No.21 Sushil Nagar Naraich, Agra, Uttar Pradesh, 282001.
Styron Pharmaceuticals Private Limited was incorporated on 18 August 2020.
The current directors of Styron Pharmaceuticals Private Limited are
The primary industry of Styron Pharmaceuticals Private Limited is Chemicals.
Styron Pharmaceuticals Private Limited is unlisted.
The authorized capital of Styron Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX